Yıl: 2022 Cilt: 33 Sayı: 5 Sayfa Aralığı: 427 - 433 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21257 İndeks Tarihi: 08-07-2022

Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study

Öz:
Background: The hepatitis B vaccination has been strongly recommended by regulatory bodies. However, there are great discrepancies between routine practices and the recommendations of regulatory agencies in many countries. We aimed to identify the barriers against Hepatitis B Vaccination (HBV) for high-risk patients by comparing the awareness, attitude, and knowledge among vaccinated and unvaccinated patients. Methods: A 34-item questionnaire was applied to 156 patients, consisting of renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, and patients with chronic hepatitis C. Multiple logistic regression analysis was employed to identify independent predictors for patients receiving the hepatitis B virus vaccination. Results: The multiple logistic regression analysis revealed that the independent risk factors against the HBV vaccination were a requirement of a separate appointment for hepatitis B virus vaccination (aOR: 3.35, 95% CI, 1.18-9.47), and fear of severe side effects that can be related with hepatitis B virus vaccination (aOR: 3.67, 95% CI, 1.18-9.47). However, taking a recommendation for hepatitis B virus vaccination at least once from a health care provider (aOR: 0.04, 95% CI, 0.01-0.11), and having a health insurance (aOR: 0.09, 95% CI, 0.01-0.55) were independent protective factors for being vaccinated. In further analysis among patients with at least a single dose of vaccine, the lack of recommendation from a health care provider for hepatitis B virus vaccination and the absence of a healthcare provider who is responsible for monitoring the completion of the 3-dose vaccination were identified as independent risk factors for failure to complete the 3-dose hepatitis B virus vaccination. Conclusion: In high-risk adults, the barriers against hepatitis B virus vaccination should be handled by a comprehensive action plan to achieve the WHO 2030 hepatitis elimination target.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. World Health Organization. Hepatitis B Fact Sheet. 2016. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 2. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc. 2007;82(8):967-975. [CrossRef]
  • 3. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(suppl 5):S45-S55. [CrossRef]
  • 4. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(1):1-31. [CrossRef]
  • 5. Zhang S, Ma Q, Liang S, et al. Annual economic burden of hepatitis B virus‐related diseases among hospitalized patients in twelve cities in China. J Viral Hepat. 2016;23(3):202-210. [CrossRef]
  • 6. Lee TA, Veenstra DL, Iloeje UH, Sullivan SD. Cost of chronic hepatitis B infection in the United States. J Clin Gastroenterol. 2004;38(10) (suppl 3):S144-S147. [CrossRef]
  • 7. Yang BM, Kim CH, Kim JY. Cost of chronic hepatitis B infection in South Korea. J Clin Gastroenterol. 2004;38(10)(suppl 3):S153-S157. [CrossRef]
  • 8. Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. Recommendations of the Advisory Committee on Immunization Practices. Recommendations of the Advisory Committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67(15):455-458. [CrossRef]
  • 9. Williams WW, Lu PJ, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR Surveill Summ. 2017;66(11):1-28. [CrossRef]
  • 10. Tenner CT, Herzog K, Chaudhari S, Bini EJ, Weinshel EH. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States. Int J Clin Pract. 2012;66(10):1009-1013. [CrossRef]
  • 11. Rhodes SD, Hergenrather KC. Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers. Prev Med. 2002;35(2):128-134. [CrossRef]
  • 12. Idilman R, Ustün C, Karayalçin S, et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant. 2003;17(5):438-443. [CrossRef]
  • 13. Chesi C, Günther M, Huzly D, et al. Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey. Transpl Infect Dis. 2009;11(6):507-512. [CrossRef]
  • 14. Kramer JR, Hachem CY, Kanwal F, Mei M, El-Serag HB. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011;53(1):42-52. [CrossRef]
  • 15. Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16-22. [CrossRef]
  • 16. Krugman S, Overby LR, Mushahwar IK, Ling CM, Frösner GG, Deinhardt F. Viral hepatitis, type B: studies on natural history and prevention re-examined. N Engl J Med. 1979;300(3):101-106. [CrossRef]
  • 17. Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis. 1991;11(2):73-83. [CrossRef]
  • 18. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20(4):992-1000. [CrossRef]
  • 19. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993;253(1337):197-201. [CrossRef]
  • 20. Jacobson RM, St Sauver JL, Finney Rutten LJ. Vaccine hesitancy. Mayo Clin Proc. 2015;90(11):1562-1568. [CrossRef]
  • 21. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7)(suppl 2):S28-S35. [CrossRef]
  • 22. Kasting ML, Head KJ, Cox D, Cox AD, Zimet GD. The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: a randomized controlled trial. Prev Med. 2019;127:105798. [CrossRef]
  • 23. Dehnen D, Herwig A, Herzer K, Weltermann B. Improving the vaccination status of liver transplant patients: effectiveness of personally addressing patients and written recommendations to family physicians after 3 years. Transpl Infect Dis. 2019;21(5):e13140. [CrossRef]
  • 24. Alshammari TM, Aljofan M, Subaie G, Hussain T. Knowledge, awareness, attitude and practice of healthcare professionals towards hepatitis B disease and vaccination in Saudi Arabia. Hum Vaccin Immunother. 2019;15(12):2816-2823. [CrossRef].
  • 25. Launay O, Le Strat Y, Tosini W, et al. Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clin Microbiol Infect. 2014;20(10):1033-1039. [CrossRef]
  • 26. Bridges CB, Watson TL, Nelson NP, et al. Challenges with hepatitis B vaccination of high risk adults: a pilot program. Vaccine. 2019;37(35):5111-5120. [CrossRef]
  • 27. Herta T, Petroff D, Engelmann C, et al. Hepatitis B vaccination in patients with liver cirrhosis evaluated for liver transplantation: a simple intervention ensures high adherence. Ann Transplant. 2019;24:527-531. [CrossRef]
APA Aslan A, Şaşmazer B, Ayar Y, Çalışkan Z, AKOVA M (2022). Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. , 427 - 433. 10.5152/tjg.2022.21257
Chicago Aslan Abdullah Tarık,Şaşmazer Başak,Ayar Yasin,Çalışkan Zeynep Cansu,AKOVA MURAT Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. (2022): 427 - 433. 10.5152/tjg.2022.21257
MLA Aslan Abdullah Tarık,Şaşmazer Başak,Ayar Yasin,Çalışkan Zeynep Cansu,AKOVA MURAT Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. , 2022, ss.427 - 433. 10.5152/tjg.2022.21257
AMA Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. . 2022; 427 - 433. 10.5152/tjg.2022.21257
Vancouver Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. . 2022; 427 - 433. 10.5152/tjg.2022.21257
IEEE Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M "Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study." , ss.427 - 433, 2022. 10.5152/tjg.2022.21257
ISNAD Aslan, Abdullah Tarık vd. "Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study". (2022), 427-433. https://doi.org/10.5152/tjg.2022.21257
APA Aslan A, Şaşmazer B, Ayar Y, Çalışkan Z, AKOVA M (2022). Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. Turkish Journal of Gastroenterology, 33(5), 427 - 433. 10.5152/tjg.2022.21257
Chicago Aslan Abdullah Tarık,Şaşmazer Başak,Ayar Yasin,Çalışkan Zeynep Cansu,AKOVA MURAT Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. Turkish Journal of Gastroenterology 33, no.5 (2022): 427 - 433. 10.5152/tjg.2022.21257
MLA Aslan Abdullah Tarık,Şaşmazer Başak,Ayar Yasin,Çalışkan Zeynep Cansu,AKOVA MURAT Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. Turkish Journal of Gastroenterology, vol.33, no.5, 2022, ss.427 - 433. 10.5152/tjg.2022.21257
AMA Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. Turkish Journal of Gastroenterology. 2022; 33(5): 427 - 433. 10.5152/tjg.2022.21257
Vancouver Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study. Turkish Journal of Gastroenterology. 2022; 33(5): 427 - 433. 10.5152/tjg.2022.21257
IEEE Aslan A,Şaşmazer B,Ayar Y,Çalışkan Z,AKOVA M "Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study." Turkish Journal of Gastroenterology, 33, ss.427 - 433, 2022. 10.5152/tjg.2022.21257
ISNAD Aslan, Abdullah Tarık vd. "Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study". Turkish Journal of Gastroenterology 33/5 (2022), 427-433. https://doi.org/10.5152/tjg.2022.21257